Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. | 10%+ Owner | Common Stock | 3.2M | $47.7M | $14.90 | Feb 14, 2024 | By 5AMVentures VI, L.P. |
Enliven Therapeutics, Inc. | 10%+ Owner | Common Stock | 635K | $9.47M | $14.90 | Feb 14, 2024 | By 5AM Opportunities I, L.P. |
Artiva Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 1.18M | Jul 22, 2024 | By 5AM Opportunities II, L.P. | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Common Stock | 1.17M | Jul 22, 2024 | By 5AM Ventures VI, L.P. | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | Jul 22, 2024 | By 5AM Ventures VI, L.P. | ||
Artiva Biotherapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Jul 22, 2024 | By 5AM Ventures VI, L.P. | ||
CinCor Pharma, Inc. | 10%+ Owner | Common Stock | 0 | $28.75 | Feb 24, 2023 | By 5AM Opportunities II, L.P. | |
CinCor Pharma, Inc. | 10%+ Owner | Common Stock | 0 | $28.75 | Feb 24, 2023 | By 5AM Opportunities I, L.P. | |
CinCor Pharma, Inc. | 10%+ Owner | Common Stock | 0 | $28.75 | Feb 24, 2023 | By 5AM Ventures VI, L.P. |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ARTV | Artiva Biotherapeutics, Inc. | Jul 22, 2024 | 6 | $14.7M | 4 | Jul 24, 2024 | 10%+ Owner |
ARTV | Artiva Biotherapeutics, Inc. | Jul 18, 2024 | 0 | $0 | 3 | Jul 18, 2024 | 10%+ Owner |
ELVN | Enliven Therapeutics, Inc. | Feb 14, 2024 | 2 | -$12.3M | 4 | Feb 16, 2024 | 10%+ Owner |
ELVN | Enliven Therapeutics, Inc. | Jan 31, 2024 | 2 | -$7.5M | 4 | Feb 2, 2024 | 10%+ Owner |
ELVN | Enliven Therapeutics, Inc. | Sep 26, 2023 | 2 | -$2.96M | 4 | Sep 28, 2023 | 10%+ Owner |
ELVN | Enliven Therapeutics, Inc. | Aug 24, 2023 | 2 | -$7.04M | 4 | Aug 28, 2023 | 10%+ Owner |
CINC | CinCor Pharma, Inc. | Feb 24, 2023 | 3 | $0 | 4 | Feb 28, 2023 | 10%+ Owner |
ELVN | Enliven Therapeutics, Inc. | Feb 23, 2023 | 0 | $0 | 3 | Mar 6, 2023 | 10%+ Owner |
CINC | CinCor Pharma, Inc. | Aug 15, 2022 | 2 | $18M | 4 | Aug 17, 2022 | 10%+ Owner |
CINC | CinCor Pharma, Inc. | Jan 11, 2022 | 7 | $7.52M | 4 | Jan 13, 2022 | 10%+ Owner |
CINC | CinCor Pharma, Inc. | Jan 6, 2022 | 0 | $0 | 3 | Jan 6, 2022 | 10%+ Owner |